These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19931460)

  • 21. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
    Murray GJ; Oliver KL; Jin FS; Brady RO
    J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors.
    Rawlings AJ; Lomas H; Pilling AW; Lee MJ; Alonzi DS; Rountree JS; Jenkinson SF; Fleet GW; Dwek RA; Jones JH; Butters TD
    Chembiochem; 2009 Apr; 10(6):1101-5. PubMed ID: 19294724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A flow cytometric assay enabling specific detection of the human lysosomal enzyme, beta-glucocerebrosidase.
    Havenga MJ; Werner AB; Valerio D; van Es HH
    Anal Biochem; 1998 Aug; 262(1):57-66. PubMed ID: 9735148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of original multivalent iminosugars as pharmacological chaperones for the treatment of Gaucher disease.
    Laigre E; Hazelard D; Casas J; Serra-Vinardell J; Michelakakis H; Mavridou I; Aerts JM; Delgado A; Compain P
    Carbohydr Res; 2016 Jun; 429():98-104. PubMed ID: 27063390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
    Chagnault V; Lalot J; Murphy PV
    ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme inhibition by iminosugars: analysis and insight into the glycosidase-iminosugar dependency of pH.
    López Ó; Qing FL; Pedersen CM; Bols M
    Bioorg Med Chem; 2013 Aug; 21(16):4755-61. PubMed ID: 23583693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A flow cytometric assay for lysosomal glucocerebrosidase.
    van Es HH; Veldwijk M; Havenga M; Valerio D
    Anal Biochem; 1997 May; 247(2):268-71. PubMed ID: 9177687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase.
    Overkleeft HS; Renkema GH; Neele J; Vianello P; Hung IO; Strijland A; van der Burg AM; Koomen GJ; Pandit UK; Aerts JM
    J Biol Chem; 1998 Oct; 273(41):26522-7. PubMed ID: 9756888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation.
    Aerts JM; Schram AW; Strijland A; van Weely S; Jonsson LM; Tager JM; Sorrell SH; Ginns EI; Barranger JA; Murray GJ
    Biochim Biophys Acta; 1988 Mar; 964(3):303-8. PubMed ID: 3349099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multivalent effect in glycosidase inhibition: probing the influence of architectural parameters with cyclodextrin-based iminosugar click clusters.
    Decroocq C; Rodríguez-Lucena D; Russo V; Mena Barragán T; Ortiz Mellet C; Compain P
    Chemistry; 2011 Dec; 17(49):13825-31. PubMed ID: 22052823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmalemmal vesicles are involved in transendothelial transport of albumin, lysosomal enzymes and mannose 6-phosphate receptor fragments in capillary endothelium.
    Willemsen R; Wisselaar HA; van der Ploeg AT
    Eur J Cell Biol; 1990 Apr; 51(2):235-41. PubMed ID: 2161765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a New α-1-
    Nakagome I; Kato A; Yamaotsu N; Yoshida T; Ozawa SI; Adachi I; Hirono S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30340368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired trafficking of mutants of lysosomal glucocerebrosidase in Gaucher's disease.
    Schmitz M; Alfalah M; Aerts JM; Naim HY; Zimmer KP
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2310-20. PubMed ID: 15982918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of gamma-hydroxyalkyl substituted piperidine iminosugars from D-glucose.
    Mane RS; Kumar KS; Dhavale DD
    J Org Chem; 2008 Apr; 73(8):3284-7. PubMed ID: 18341351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imino sugars are potent agonists of the human glucose sensor SGLT3.
    Voss AA; Díez-Sampedro A; Hirayama BA; Loo DD; Wright EM
    Mol Pharmacol; 2007 Feb; 71(2):628-34. PubMed ID: 17110502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular probes: Getting lucky in the lysosome.
    Goddard-Borger ED; Wennekes T; Withers SG
    Nat Chem Biol; 2010 Dec; 6(12):881-3. PubMed ID: 21079598
    [No Abstract]   [Full Text] [Related]  

  • 37. Multivalent iminosugars to modulate affinity and selectivity for glycosidases.
    Diot J; García-Moreno MI; Gouin SG; Ortiz Mellet C; Haupt K; Kovensky J
    Org Biomol Chem; 2009 Jan; 7(2):357-63. PubMed ID: 19109682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a gene cluster that initiates azasugar biosynthesis in Bacillus amyloliquefaciens.
    Clark LF; Johnson JV; Horenstein NA
    Chembiochem; 2011 Sep; 12(14):2147-50. PubMed ID: 21786380
    [No Abstract]   [Full Text] [Related]  

  • 39. Current and Novel Aspects on the Non-lysosomal β-Glucosylceramidase GBA2.
    Massimo A; Maura S; Nicoletta L; Giulia M; Valentina M; Elena C; Alessandro P; Rosaria B; Sandro S
    Neurochem Res; 2016 Feb; 41(1-2):210-20. PubMed ID: 26603294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclodextrin-based iminosugar click clusters: the first examples of multivalent pharmacological chaperones for the treatment of lysosomal storage disorders.
    Decroocq C; Rodríguez-Lucena D; Ikeda K; Asano N; Compain P
    Chembiochem; 2012 Mar; 13(5):661-4. PubMed ID: 22344719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.